Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
10.87
-0.32 (-2.86%)
May 26, 2026, 2:00 PM EDT - Market open
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $215.14 million as of May 26, 2026. Its market cap has decreased by -62.22% in one year.
Market Cap
215.14M
Enterprise Value
-43.42M
1-Year Change
-62.22%
Ranking
Category
Stock Price
$10.87
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $215.14M, a decrease of -44.17%. That is a compound annual growth rate of -9.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 221.47M | -64.30% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 234.19M |
| Cybin | 234.17M |
| Humacyte | 233.12M |
| Voyager Therapeutics | 229.60M |
| Codexis | 226.33M |
| Atrium Therapeutics | 223.91M |
| Whitehawk Therapeutics | 221.93M |
| NervGen Pharma | 218.26M |